By following key strategies, companies can reduce the risk and increase the benefits of outsourcing analytical development and testing
John Ruesch
Advertisement
John Ruesch is the associate director in QC/Stability/Compliance in the Analytical Research and Development of Pfizer Global Biologics
Articles by John Ruesch
Advertisement
Latest Updated Articles
Advertisement
Advertisement
Trending on BioPharm International
1
Amgen’s Dazodalibep Reduces Systemic Disease Activity in Phase 3 Sjögren’s Trial
2
FDA Reportedly Pauses National Priority Voucher Pilot and Pauses CRL Publication
3
ImvivaBio’s Dual-Target Allogeneic CAR-T Sustains Lupus Remission Through 12 Months
4
FDA Clears IND for Biolojic’s BD200, the First AI-Designed Multibody ADC to Enter Clinical Trials
5